NYSE · Healthcare
Owlet, Inc. (OWLT)
As-reported financials and recent SEC filings for Owlet, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$105.7M
Net income
$-39.7M
Net margin
-37.5%
Diluted EPS
—
ROE
-208.4%
P/E (TTM)
—
Market cap
—
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2023 | FY2023 | FY2021 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $105.7M | $78.1M | $54.0M | $69.2M | $75.8M |
| Gross profit | $53.5M | $39.3M | $22.6M | $23.3M | $35.1M |
| Operating income | $-8.3M | $-20.2M | $-28.6M | $-84.6M | $-55.8M |
| Net income | $-39.7M | $-12.5M | $-32.9M | $-79.3M | $-71.7M |
| Diluted EPS | — | $-1.57 | $-4.53 | $-9.98 | $-9.04 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-07-01
View on EDGAR →ARS2026-06-30
View on EDGAR →DEFA14A2026-06-30
View on EDGAR →DEF 14A2026-06-30
View on EDGAR →8-K2026-06-05
View on EDGAR →S-82026-05-11
View on EDGAR →10-Q2026-05-11
View on EDGAR →8-K2026-05-07
View on EDGAR →Largest Healthcare peers
Go deeper on OWLT
Search Owlet, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.